Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

ENETS Abstract Search

#1108 Regression of Paraneoplastic Optic Neuropathy Associated with Glucagonoma After Surgical Resection

Introduction: Glucagonomas-associated ocular manifestations have been exceptionally reported.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Defour L, De Mestier L, Diebold M, Arndt C, Kianmanesh R,

Keywords: Paraneoplastic syndrome, glucagonoma, optic neuropathy.,

#1064 Development of Effective Prophylaxis Against Intraoperative Carcinoid Crisis

Introduction: Patients with foregut and midgut neuroendocrine tumors (NETs) can experience life-threatening carcinoid crises during anesthesia. The prophylactic use of a pre-, intra- and post-operative high dose continuous octreotide infusion was evaluated for its ability to prevent carcinoid crises during cytoreductive surgeries.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Woltering E

Authors: Woltering E, Diebold A, Stevens M, Wang Y, Boudreaux J,

Keywords: carcinoid crisis,

#594 Neurokinin A Levels Predict Survival in Patients with Well-Differentiated Small Bowel Neuroendocrine Tumors

Introduction: Recent European investigations demonstrated that persistently elevated (> 50 pg/ml) plasma neurokinin A (NKA) levels are associated with poor short-term survival in patients with midgut neuroendocrine tumors (NETS).

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author:

Authors: Diebold A, Boudreaux J, Wang Y, Anthony L, Uhlhorn A,

Keywords: midgut, neuroendocrine tumors (NETs), Neurokinin A (NKA), survival,

#386 A Prospective Evaluation of the Effects of Chronic Proton Pump Inhibitor Use on Plasma Biomarker Levels in Humans

Introduction: Proton pump inhibitors (PPIs) are used primarily to treat gastroesophageal reflux disease. PPI-induced achlorhydria increases circulating gastrin and chromogranin A (CGA). CGA is a widely used biomarker for the diagnosis and follow-up for gut-based neuroendocrine tumors (NETs). PPI-induced increases in CGA or gastrin may falsely suggest the presence of a NET when none exists. Pancreastatin, a fragment of CGA, is also commonly used to diagnose and follow NETs.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Raines D, Chester M, Diebold A, Mamikunian P, Anthony C,

Keywords: Chromogranin A, gastrin, pancreastatin, neuroendocrine tumor (NET),

#385 Treatment of Small Bowel Neuroendocrine Tumor (NETS): A Single Center's Experience

Introduction: Neuroendocrine tumors (NETS) of the gastrointestinal tract are rare, slow-growing neoplasms. Long-term management of these tumors varies among centers.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Woltering E, Diebold A, Anthony L, Wang Y, Boudreaux J,

Keywords: survival,